Hangzhou Biotest Biotech Co Ltd (688767) - Total Liabilities

Latest as of March 2026: CN¥121.73 Million CNY ≈ $17.81 Million USD

Based on the latest financial reports, Hangzhou Biotest Biotech Co Ltd (688767) has total liabilities worth CN¥121.73 Million CNY (≈ $17.81 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Also explore 688767 shareholders equity momentum to track the company's year-over-year net asset growth rate.

Hangzhou Biotest Biotech Co Ltd - Total Liabilities Trend (2017–2025)

This chart illustrates how Hangzhou Biotest Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. See free cash flow generation of Hangzhou Biotest Biotech Co Ltd to measure how efficiently the company converts operating cash flow to free cash.

Hangzhou Biotest Biotech Co Ltd Competitors by Total Liabilities

The table below lists competitors of Hangzhou Biotest Biotech Co Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Strive Asset Management NASDAQ:ASST	USA	$26.31 Million
Wuxi Huadong Heavy Machinery Co Ltd SHE:002685	China	CN¥850.48 Million
Hubei Jiuzhiyang Infrared System Co Ltd SHE:300516	China	CN¥611.14 Million
Jiangyin Electrical Alloy Co Ltd SHE:300697	China	CN¥1.34 Billion
Dogus Otomotiv Servis ve Ticaret AS IS:DOAS	Turkey	TL58.84 Billion
Decai Decoration Co Ltd SHG:605287	China	CN¥9.25 Billion
Lahav LR Real Estate Ltd TA:LAHAV	Israel	ILA1.06 Billion
MeiraGTx Holdings PLC NASDAQ:MGTX	USA	$250.22 Million

Liability Composition Analysis (2017–2025)

This chart breaks down Hangzhou Biotest Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see Hangzhou Biotest Biotech Co Ltd (688767) total market value.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	14.11	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.05	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Hangzhou Biotest Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Hangzhou Biotest Biotech Co Ltd (2017–2025)

The table below shows the annual total liabilities of Hangzhou Biotest Biotech Co Ltd from 2017 to 2025.

Year	Total Liabilities	Change
2025-12-31	CN¥168.17 Million ≈ $24.61 Million	-11.39%
2024-12-31	CN¥189.79 Million ≈ $27.77 Million	+19.50%
2023-12-31	CN¥158.82 Million ≈ $23.24 Million	-15.93%
2022-12-31	CN¥188.92 Million ≈ $27.64 Million	-41.58%
2021-12-31	CN¥323.36 Million ≈ $47.32 Million	+69.39%
2020-12-31	CN¥190.89 Million ≈ $27.93 Million	+125.92%
2019-12-31	CN¥84.50 Million ≈ $12.36 Million	+49.60%
2018-12-31	CN¥56.48 Million ≈ $8.27 Million	+17.96%
2017-12-31	CN¥47.88 Million ≈ $7.01 Million	--

About Hangzhou Biotest Biotech Co Ltd

SHG:688767 China Biotechnology

Market Cap

$909.71 Million

CN¥6.22 Billion CNY

Market Cap Rank

#9420 Global

#2413 in China

Share Price

CN¥41.63

Change (1 day)

+12.51%

52-Week Range

CN¥30.56 - CN¥48.37

All Time High

CN¥125.45